Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biomarin Pharmaceutical (BMRN) Q4 2022 Earnings
BMRN
+0.72%
26
Oct
Confirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.33
-0.16
0.01
0.18
Details
Expected EPS
-0.02
Actual EPS
-0.04
Surprise EPS
-0.02
Surprise Percent
+100%
Description
Biomarin Pharmaceutical (BMRN) has reported earnings of -0.04 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login